
Taro Pharmaceutical (TARO) Lags Q2 Earnings and Revenue Estimates
Published on October 28, 2021
Taro (TARO) delivered earnings and revenue surprises of -35.29% and -13.86%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
